BREAKINGON
approval search result
FDA Clears Path for Sarepta's Duchenne Muscular Dystrophy Gene Therapy

FDA Clears Path for Sarepta's Duchenne Muscular Dystrophy Gene Therapy

HEALTH - 7/29/2025

In a surprising turn of events, the FDA has allowed Sarepta Therapeutics to resume shipments of its gene therapy, Elevidys, for younger Duchenne muscular dystrophy patients who can walk, despite concerns over previous fatalities.

Revolutionary HIV Prevention Drug Gets EU Approval: A Game Changer in Public Health

Revolutionary HIV Prevention Drug Gets EU Approval: A Game Changer in Public Health

HEALTH - 7/26/2025

The EU has recommended lenacapavir, an injectable drug for HIV prevention, which could drastically reduce transmission rates. With nearly 100% effectiveness, it promises a new era in combating HIV.

Revolutionary HIV Prevention Drug Recommended for EU Approval

Revolutionary HIV Prevention Drug Recommended for EU Approval

HEALTH - 7/26/2025

The European Medicines Agency has recommended the approval of lenacapavir, a twice-yearly injectable drug that could revolutionize HIV prevention and significantly reduce transmission rates globally.

Paramount-Skydance Merger: A Game-Changer in the Media Landscape

Paramount-Skydance Merger: A Game-Changer in the Media Landscape

ENTERTAINMENT - 7/26/2025

Paramount Global is set to finalize its $8bn merger with Skydance Media, marking a pivotal shift in the entertainment industry under the Trump administration's influence. The merger's approval has raised eyebrows amidst political tensions and a recent lawsuit settlement with Trump.

FCC Approves Controversial $8 Billion Merger of CBS and Skydance Media

FCC Approves Controversial $8 Billion Merger of CBS and Skydance Media

ENTERTAINMENT - 7/25/2025

The FCC has greenlit the $8 billion merger between CBS's parent company Paramount and Skydance Media, amidst accusations of political influence and promises of reform in news coverage.

Sarepta Therapeutics Faces Hurdles in Reviving Controversial Gene Therapy

Sarepta Therapeutics Faces Hurdles in Reviving Controversial Gene Therapy

HEALTH - 7/22/2025

Sarepta Therapeutics' gene therapy for Duchenne muscular dystrophy is on hold due to safety issues. An FDA official warns the path to market approval is fraught with challenges, especially after patient deaths linked to liver injuries.

Trump's Controversial Distractions Amid Epstein Files Controversy

Trump's Controversial Distractions Amid Epstein Files Controversy

POLITICS - 7/22/2025

As the Epstein scandal looms, Trump stirs controversy with demands for the Washington Commanders to change their name. Critics suggest he's trying to distract from pressing issues. Can he handle the heat?

Jon Stewart Questions The Daily Show's Future Amid Skydance-Paramount Merger

Jon Stewart Questions The Daily Show's Future Amid Skydance-Paramount Merger

ENTERTAINMENT - 7/20/2025

Jon Stewart expresses uncertainty about the future of The Daily Show in light of the Skydance-Paramount merger. He reflects on the show's value amidst industry changes and recent cancellations.

House Approves Trump's $9 Billion Cut to Public Broadcasting and Foreign Aid

House Approves Trump's $9 Billion Cut to Public Broadcasting and Foreign Aid

POLITICS - 7/18/2025

In a historic move, the House has approved President Trump's request to cut $9 billion from public broadcasting and foreign aid, raising concerns among Democrats and some Republicans. This unprecedented action could reshape funding priorities and affects essential services.

House Approves $9 Billion Funding Rescission, Threatening Public Broadcasting

House Approves $9 Billion Funding Rescission, Threatening Public Broadcasting

POLITICS - 7/18/2025

The House has voted to cut $9 billion in funding, eliminating federal support for NPR and PBS. This controversial decision faces backlash from both sides of the aisle, raising concerns over the future of public broadcasting.

Breakingon.com is an independent news platform that delivers the latest news, trends, and analyses quickly and objectively. We gather and present the most important developments from around the world and local sources with accuracy and reliability. Our goal is to provide our readers with factual, unbiased, and comprehensive news content, making information easily accessible. Stay informed with us!
© Copyright 2025 BreakingOn. All rights reserved.